ANIK vs ECL · rev $119.9M vs P/E 35, rev $4.01B
Anika Therapeutics Inc (ANIK) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported ANIK revenue for 2024-12-31 was $119.9M. Net income was -$56.4M. Revenue was down 0.7% from 2023-12-31 to 2024-12-31. ANIK currently screens at market cap $161.3M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
ANIK currently screens at market cap $161.3M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the ANIK and ECL stock pages for the full models.
Not investment advice.